论文部分内容阅读
本文报告日本京都大学医院和大阪红十字医院于1980~1981年对25例鼻咽癌病人进行六种EB病毒抗体测定的结果。除了2例为以前治愈生存五年以上的随诊病人之外,其他均为最近确诊的病人.这些病人大多对放射治疗敏感,个别放射抗拒的病人再行手术或化学治疗。按世界卫生组织病理分类标准,非角化型癌和未分化癌占84%;按国际抗癌联盟(UICC)分期标准,Ⅲ、Ⅳ期病人占76%。所有血清标本都用荧光免疫法
This article reports the results of six EBV antibody tests performed on 25 patients with nasopharyngeal carcinoma from 1980 to 1981 at Kyoto University Hospital and Osaka Red Cross Hospital. Except for 2 cases of follow-up patients who had previously cured and survived for more than five years, others were recently diagnosed. Most of these patients are sensitive to radiation therapy, and individual radiation-resistance patients undergo surgery or chemotherapy. According to the World Health Organization pathological classification criteria, non-keratinized and undifferentiated cancers accounted for 84%; according to the International Union Against Cancer (UICC) staging criteria, patients with stage III and IV accounted for 76%. All sera samples were immunofluorescent